Expression and Clinical Significance of Lactate Dehydrogenase A in Colon Adenocarcinoma

10Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Lactate dehydrogenase A (LDHA) is an important glycolytic enzyme that promotes glycolysis and plays a crucial role in cancer cell invasion and immune infiltration. However, the relevance of LDHA in colon adenocarcinoma (COAD) remains unclear. In this study, we analyzed the correlation between the expression of LDHA and clinicopathological characteristics in COAD using immunohistochemistry analysis, and then used integrative bioinformatics analyses to further study the function and role of LDHA in COAD. We found that LDHA was highly expressed in COAD tissues compared with adjacent normal tissues, and that COAD patients with high LDHA expression levels showed poor survival. In addition, LDHA expression was closely associated with the immune infiltrating levels of CD8+ T cells, neutrophils, and dendritic cells. Our findings highlight the potential role of LDHA in the tumorigenesis and prognosis of COAD. Furthermore, our results indicate that COAD is a novel immune checkpoint in the diagnosis and treatment of COAD.

Cite

CITATION STYLE

APA

Wang, Y., Nie, H., Liao, Z., He, X., Xu, Z., Zhou, J., & Ou, C. (2021). Expression and Clinical Significance of Lactate Dehydrogenase A in Colon Adenocarcinoma. Frontiers in Oncology, 11. https://doi.org/10.3389/fonc.2021.700795

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free